
Category: Research


FSR Announces New Small Grant Awardee
FSR’s Small Grant Program The FSR Small Grant aims to support smaller scale or pilot research projects, which can be supported either singularly by FSR or through a partnership with additional funders. The goal of this program is to provide bridge funding for...
New FSR Fellowship Awardee
FSR launched its Clinical and Research Fellowship Program in Fall 2017. We’ve invested over $1 million into this program, which aims to increase the number of specialized doctors and researchers in the sarcoidosis space. This investment in early career...
Advancing how we Diagnose and Treat Sarcoidosis
Sarcoidosis is difficult to treat for many reasons. Mainly, there is not one clear way to treat sarcoidosis because it manifests in many forms and the cause is unknown. For this reason, there are also many ways to diagnose sarcoidosis, making it a diagnosis of...
aTyr Pharma Announces Positive Interim Safety Results from Ongoing Phase 1b/2a Clinical Trial of ATYR1923
FSR has partnered with aTyr Pharma, Inc. to help inform patients about an ongoing clinical trial for ATYR1923, a potential new treatment for pulmonary sarcoidosis (ATYR1923-C-002, NCT03824392.) aTyr recently issued a press release, republished with permission below,...
Clinical Trial: Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
New clinical trial opportunity in New Haven, CT!